Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine Monotherapy for Partial Seizures
NCT00355082Phase 3Completed
- Sponsor
- GSK
- Start
- May 2006
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of lamotrigine in epilepsy, sponsored by GSK. Started May 2006; status: completed.
02
Drugs
lamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00355082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00355082.